A Study of Atezolizumab Plus Nab-Paclitaxel in the Treatment of Unresectable Locally Advanced or Metastatic PD-L1-Positive Triple-Negative Breast Cancer
Clinical trial NCT04148911 · COMPLETED
Trial details
- NCT number
- NCT04148911
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-10
- Primary completion
- 2024-12-15
- Enrollment
- 184
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.